Comprehensive Assessment of Fluid Status by Point-of-Care Ultrasonography : Kidney360

Journal Logo

Review Article

Comprehensive Assessment of Fluid Status by Point-of-Care Ultrasonography

Argaiz, Eduardo R.; Koratala, Abhilash; Reisinger, Nathaniel

Author Information
Kidney360 2(8):p 1326-1338, August 2021. | DOI: 10.34067/KID.0006482020
  • Open


The management of complex fluid and electrolyte disorders is central to the practice of nephrologists. The sensitivity of physical examination alone to determine fluid status is limited, precluding accurate clinical decision making. Point-of-care ultrasonography (POCUS) is emerging as a valuable, noninvasive, bedside diagnostic tool for objective evaluation of physiologic and hemodynamic parameters related to fluid status, tolerance, and responsiveness. Rapid bedside sonographic evaluation can obtain qualitative data on cardiac function and quantitative data on pulmonary congestion. Advanced POCUS, including goal-directed Doppler echocardiography, provides additional quantitative information, including flow velocities and pressures across the cardiac structures. Recently, abnormal Doppler flow patterns in abdominal organs secondary to increased right atrial pressure have been linked to congestive organ damage, adding another component to the hemodynamic assessment. Integrating POCUS findings with clinical and laboratory data can further elucidate a patient’s hemodynamic status. This drives decisions regarding crystalloid administration or, conversely, diuresis or ultrafiltration and allows tailored therapy for individual patients. In this article, we provide an overview of the focused assessment of cardiovascular function and pulmonary and venous congestion using POCUS and review relevant literature.


A 63-year-old man with a medical history of hypertension, obesity, and heart failure (HF) with reduced ejection fraction presents to the nephrology clinic for assessment of an elevated serum creatinine. His baseline serum creatinine was approximately 0.6–0.8 mg/dl. He complains of abdominal distension, loose stools, and dyspnea on exertion. Medications include carvedilol, lisinopril, isosorbide mononitrate, and hydralazine. Diuretics were held by the referring physician due to a rise in creatinine. Physical examination demonstrates BP of 92/59 mm Hg with a heart rate of 65 bpm. Cardiopulmonary exam reveals pedal edema, but no obvious jugular venous distention, rales, or third heart sound. Urine sediment is bland. Review of chest roentgenogram obtained in the primary care setting shows no evidence of pulmonary edema or pleural effusions. Laboratory studies show stable serum creatinine 1.4 mg/dl after discontinuation of diuretics. What is the next step?


Assessment of fluid and hemodynamic status is a critical skill for nephrologists, central to almost every consult from hypertension and electrolyte disorders to management of AKI and ESKD. Fluid status assessment has a storied tradition in which physical exam signs of jugular venous distention, third heart sounds, rales, and peripheral edema have been learned and reproduced by generations of physicians. These signs are helpful in extreme cases, but are insensitive for the detection of volume overload (1). Radiographic signs of volume overload, such as pleural effusions and Kerley B lines, aid in fluid status assessment, but lack sensitivity (2). Natriuretic peptides and pulmonary artery catheters also have limitations (3,4). In the past 30 years, point-of-care ultrasonography (POCUS) has expanded from a niche subspecialty skill to a cornerstone of bedside diagnosis (5,6). Ultrasound allows us to directly visualize the body in a way that was previously inaccessible. POCUS involves answering focused clinical questions using bedside ultrasonography and increases the sensitivity of the conventional physical examination (7891011–12). As we move forward, ultrasonographic indicators of fluid status are being developed and validated. Some are intuitive to our understanding of physiology, and others are novel markers of previously unknown significance (Figure 1). Having said that, POCUS findings should be interpreted in conjunction with other clinical parameters—such as vital signs, body weight, mucous membrane examination, capillary refill time, and axillary moisture—and not viewed as an alternative to physical examination or standard imaging studies. We describe the most well-validated indices of fluid status: focused sonographic assessment of the heart, abdominal veins, and lungs (the pump-pipes-leaks approach) (13) to gain insight into systemic hemodynamics and guide fluid management decisions.

Figure 1.:
Key components of the comprehensive sonographic evaluation of the fluid volume status using the B-mode and Doppler ultrasound. POCUS, point-of-care ultrasonography.

Lung Ultrasound

Extravascular lung water (EVLW), or the fluid content in the lung interstitium, is an important indicator of fluid status, often guiding management decisions in clinical practice. It essentially depends on left ventricular (LV) filling pressures and permeability of the pulmonary vasculature. In the recent past, lung ultrasound (LUS) has emerged as a valuable bedside tool to detect pulmonary congestion, even before it is clinically apparent (14). Moreover, LUS is technically the least challenging of all of the sonographic applications described in this review. There are data suggesting that nephrologists can be effectively trained to measure EVLW using LUS by an entirely internet-based program (15).


LUS primarily involves interpretation of the artifacts rather than visualization of the pulmonary parenchyma because air is strongly reflective to the ultrasound beam. In normal aerated lung, the only detectable structure is the pleura, which appears as a shimmering hyperechoic (bright) horizontal line in between the rib shadows. The shimmer or synchronous horizontal movement with respiration denotes pleural sliding. A-lines are equidistant hyperechoic horizontal lines seen on a normal LUS (Figure 2A). These are reverberation artifacts formed due to multiple reflections of the ultrasound beam between the transducer and the pleura with underlying air-filled lung. When the air content in the lung decreases due to transudate or exudate in the interstitium, vertical hyperechoic artifacts are seen, termed the B-lines (Figure 2B). These are the ultrasound equivalents of the Kerley B lines seen on a chest radiograph, and they provide a semiquantitative estimate of the amount of EVLW. B-lines arise from the pleural line, extend to the end of the image without fading, and move synchronously with lung sliding. A positive “B-line region or zone” is defined as the presence of three or more B-lines in a longitudinal plane between two ribs. Two or more positive regions bilaterally constitutes “interstitial syndrome” and indicates diffuse pulmonary edema (16). B-lines can also be seen in conditions other than cardiogenic pulmonary edema—such as focal pneumonia, acute respiratory distress syndrome, pulmonary fibrosis, and contusion—and, hence, should be interpreted in the appropriate clinical context. These conditions are typically associated with thickened/irregular pleural line and nonhomogeneous distribution of B-lines. When the air content in the lung further decreases, such as in alveolar consolidation, lung parenchyma can be visualized on ultrasound similarly to that of liver and spleen (Figure 2C). In contrast, pleural effusion appears as an anechoic (black) space above the diaphragm, typically surrounding the atelectatic or consolidated lung (Figure 2D).

Figure 2.:
Common lung ultrasound findings. Sonographic images demonstrating (A) normal lung with A-lines (arrows); (B) vertical B-lines (arrows), indicating interstitial edema. Arrowhead points to the pleural line. (C) Consolidated lung (arrow); (D) pleural effusion (asterisk) above the diaphragm (a rrow). 'LOGIQ P9' and the letter 'P' in the images indicate ultrasound screen orientation markers.

Most research studies, particularly in patients with ESKD, used a 28-zone scanning technique to obtain the total B-line count, which involves scanning of the anterior and lateral chest from the second to fourth (on the right side to the fifth) intercostal spaces and from the parasternal to midaxillary lines on each side (Figure 3A). However, in routine clinical practice, an eight-zone scanning technique is frequently used in which two anterior and two lateral areas are examined on each hemithorax (Figure 3B) (17). Recently, Torino et al. (18) showed that the eight-zone technique correlates well with the classic 28-zone score and also retains its prognostic significance (discussed below).

Figure 3.:
Lung ultrasound technique. (A) The 28- and (B) eight-zone lung ultrasound scanning techniques. Lower panel demonstrates the transducer position, which should be perpendicular to the chest wall, following its curvature to obtain optimal images. ICS, intercostal space. Human body photograph obtained from Shutterstock; photo credit, Albina Glisic. Illustration made using Biorender.

Diagnostic Performance

The diagnostic performance of LUS to detect pulmonary congestion is far superior compared with auscultation. For example, in a study including 79 patients receiving hemodialysis who were deemed to be at higher cardiovascular risk, only about half of those with severe congestion on LUS (defined as >30 B-lines on a 28-zone scan) had crackles on lung auscultation. Likewise, in patients with moderate congestion on LUS (15 to <30 B-lines), the prevalence of crackles was only 31% (1).

In patients with acute decompensated heart failure, LUS was shown to be more sensitive for detection of pulmonary edema than chest radiography, which is the typical first-line imaging (2). In addition, LUS has demonstrated substantial correlation with cardiac catheterization–derived LV end-diastolic pressure, making it a valuable adjunct to echocardiography and clinical variables in the management of patients with HF (19).

Prognostic Significance

LUS-detected pulmonary congestion is associated with adverse outcomes, even in patients who are asymptomatic. For instance, in a multicenter observational study including 392 patients with ESKD who were on hemodialysis, those with very severe congestion (>60 B-lines on a 28-zone scan) had a 4.2-fold risk of death (hazard ratio, 4.20; 95% CI, 2.45 to 7.23) and a 3.2-fold risk of cardiac events (hazard ratio, 3.20; 95% CI, 1.75 to 5.88) after adjusting for HF class and other risk factors compared with those having mild or no congestion (<15 B-lines) (20).

Analogously, in the context of HF, residual lung congestion at hospital discharge and in the outpatient clinic has been shown to be a strong predictor of outcome (2122–23).

Role in Guiding the Therapy

Because LUS provides dynamic information, the change in B-line count can be used to monitor the effectiveness of decongestive/ultrafiltration therapy and titrate it accordingly (242526–27). In a recent randomized controlled trial including 71 patients with ESKD who were “clinically euvolemic,” those who underwent prehemodialysis, LUS-guided, dry-weight reduction achieved a greater reduction in weight compared with those receiving standard care, correlating with the change in number of B-lines (–5.3 in active group versus +2.2 in controls). In addition, the magnitude of 48-hour ambulatory BP reduction was significantly greater in the active group at 8 weeks (systolic –6.61 versus –0.67 mm Hg and diastolic –3.85 versus –0.55, P=0.03) (28).

Similarly, in patients with acute exacerbation of HF, B-line count has been shown to consistently decrease with diuretic therapy soon after presentation, thereby guiding further management (29). In ambulatory patients with chronic HF, an eight-zone, LUS-guided diuretic therapy was associated with a significant reduction in HF-related urgent care visits compared with standard care (30). Clinical trials are in progress that may provide further insights into long-term outcomes of LUS-guided therapy (31).

Focused Cardiac Assessment

Hemodynamic assessment is predicated on the basic knowledge of cardiac function and the presence of pathologies. In contrast to referral echocardiography, focused cardiac ultrasound (FOCUS) is a limited study aimed at answering specific questions, such as evaluation of the left and right ventricular function and presence or absence of pericardial effusions. Most commonly, FOCUS consists of a series of five, two-dimensional, echocardiographic clips without spectral Doppler, in which images of the heart are obtained in orthogonal planes to provide the relevant physiologic information (detailed in Figure 4) (32,33). Further clues to fluid status can be gleaned from additional studies using Doppler ultrasonography. Table 1 summarizes the image acquisition of basic echocardiographic views, common structures visualized, sonographic parameters, and pathologies assessed in each view. A brief note on common pathologies is provided below.

Figure 4.:
Basic echocardiographic views. (A) Parasternal long axis; (B) parasternal short axis; (C) apical four-chamber; (D) subxiphoid; (E) inferior vena cava. Green arrows indicate the direction of the transducer orientation marker. IVC, inferior vena cava; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. Human body illustration obtained from Shutterstock; photo credit, Albina Glisic.
Table 1. - Summary of the basic echocardiographic views
FOCUS View Image Acquisition Structures Key Assessments Common Pathologies
PSLA Parasternal third to fifth intercostal space, indicator to patient’s right shoulder RV, LV, LA, LVOT, AV, MV, descending aorta Visual assessment of LV EF LV dysfunction, pericardial effusion, left-sided pleural effusion posterior to descending aorta
PSSA Second to fourth intercostal space, indicator to left shoulder RV, LV, interventricular septum Visual assessment of LV EF and LV shape LV dysfunction, septal flattening, or shift indicative of RV dysfunction, pericardial effusion
Apical Point of maximum impulse, indicator to left axilla RA, LA, RV, LV, LVOT, MV, TV RV/LV comparison, color Doppler of tricuspid and mitral valves RV failure, pericardial effusion, valvular regurgitation
SX Below the xiphoid process, indicator to patient’s L RA, LA, RV, LV Pericardium Pericardial effusion, LV dysfunction
Table includes the image acquisition, common structures, sonographic parameters, and pathologies assessed in each view. Note that this list of assessments/pathologies is not exhaustive, and each pathology can be seen in multiple views. FOCUS, focused cardiac ultrasound; PSLA, parasternal long axis view; RV right ventricle; LV left ventricle; LA left atrium; LVOT, left ventricular outflow tract; AV aortic valve; MV mitral valve; EF, ejection fraction; PSSA, parasternal short axis view; RA, right atrium; TV, tricuspid valve; SX subxiphoid view.

Pericardial Effusion

Pericardial effusion is an important cause of hypotension and hemodynamic compromise, which can be quickly identified on FOCUS. It appears as an anechoic (black) space between the two pericardial layers. Parasternal long-axis and subcostal views allow better visualization of the effusion, although it is generally identifiable on all of the standard FOCUS views (Figure 5A). In terms of severity, separation between the pericardial layers in diastole of <1 cm is considered mild, whereas 1–2 cm is considered moderate and >2 cm is considered severe effusion (34).

Figure 5.:
Common findings on focused cardiac ultrasound. (A) Pericardial effusion (asterisk) surrounding the heart, seen from the subcostal window. (B) D-sign: interventricular septal flattening seen from the parasternal short axis view. (C) Plethoric IVC (arrow). (D) Small IVC (arrow).

LV Systolic Dysfunction

Qualitative estimation or “eyeballing” of the LV ejection fraction is another key component of FOCUS, which involves observing wall thickening and motion during the cardiac cycle. In general, the LV walls should approximate by one fourth or more in parasternal views. In patients with depressed LV function, both wall thickening and inward motion are decreased. Conversely, a hyperdynamic ventricle, i.e., where ventricular walls/papillary muscles in the parasternal short axis view almost touch at end-systole, is indicative of volume depletion in the appropriate clinical context.

Relative Chamber Size

A normal right ventricle (RV) cavity diameter is less than two thirds of the LV and can quickly dilate with pressure or volume overload. Apical four-chamber and parasternal short axis views are good for assessing this. With volume overload, the RV becomes dilated, and the interventricular septum is flattened in diastole, giving the appearance of “D” to the LV in the parasternal short axis view. This is called the “D-sign” (Figure 5B). Although such patients are hypotensive, empirically administering intravenous fluids causes further compromise of the LV cavity and reduced cardiac output.

Right Atrial Pressure

Inferior vena cava (IVC) ultrasound is used to estimate right atrial pressure (RAP) and get an idea of the resistance to venous return. In patients who are spontaneously breathing, the IVC collapses during inspiration due to negative intrathoracic pressure. An IVC diameter of ≤2.1 cm and collapsibility of >50% with a sniff indicates normal RAP of 3 mm Hg (0–5 mm Hg), an IVC diameter of >2.1 cm with <50% inspiratory collapse indicates high RAP of 15 mm Hg (10–20 mm Hg), and scenarios in between correspond to an intermediate value of 8 mm Hg (5–10 mm Hg) (35). Figure 5, C and D, demonstrates sonographic images of large and small IVC obtained from a patient with HF and volume depletion, respectively. However, these cutoffs cannot be applied in patients who are mechanically ventilated because the IVC is dilated at baseline due to positive pressure ventilation and may not collapse at all during respiration. Although novice POCUS users are enthusiastic about IVC ultrasound because it is relatively easy to learn, interpreting it in isolation is subject to numerous pitfalls. For example, small collapsible IVC is seen in normal state of health and equating it with volume depletion, without considering the clinical context, leads to unnecessary fluid administration. Moreover, the magnitude of the respiratory effort significantly affects collapsibility (for example, a frail elderly woman versus a muscular young man), altering the interpretation. Furthermore, technical factors—such as obesity, surgical dressings, increased intra-abdominal pressure, or mistaking aorta or dilated bowel for IVC—can result in errors. Depending on how the ultrasound beam is aimed, it may not depict the true diameter of the vessel. Notably, studies demonstrate moderate to poor inter-rater agreement between IVC measurements (36,37). Although IVC is a good indicator of central venous pressure (CVP), it is not reliable to assess fluid responsiveness (38). Therefore, IVC ultrasound should be interpreted in conjunction with other POCUS findings and the overall clinical picture.

Users with further training in Doppler echocardiography assess additional parameters, such as cardiac output and its response to fluid administration, LV filling pressures, and right ventricular filling pressures at the bedside (39).

Venous Doppler

Organ dysfunction in HF is closely related to venous congestion (40). CVP is the strongest hemodynamic determinant for the development of worsening renal function in patients with decompensated HF (41). Normal and abnormal patterns of flow in abdominal and central veins result from retrograde transmission of CVP (42). POCUS can enhance the clinical evaluation of venous congestion using venous Doppler in addition to IVC ultrasound (43,44). Figure 6 illustrates the technique of obtaining the sonographic images of hepatic, portal, and intrarenal veins.

Figure 6. Components of sonographic venous congestion assessment. :
(A) IVC and hepatic veins (arrowheads) in long and transverse axes, visualized from the subxiphoid scan position. (B) Top shows the hepatic veins (arrowheads) and portal vein from the lateral scan plane obtained by placing the transducer along the anterior axillary line with the orientation marker facing supero-anteriorly. Bottom shows the color Doppler image of the kidney obtained by placing the transducer along the midaxillary line with the orientation marker facing supero-posteriorly. Illustrations made using Biorender.

Hepatic Vein Doppler

Blood flow in the hepatic veins (HVs) is pulsatile, and changes in its velocity reflect changes in RAP. The normal HV flow pattern consists of two antegrade waves (a larger systolic [S] and a smaller diastolic [D] wave corresponding to CVP “X” and “Y” descent, respectively) and one or two retrograde waves (a larger “A” wave and smaller “V” wave corresponding to CVP “A” and “V” waves, respectively). Frequently, the V wave is not seen (Figure 7A) (26). Understanding the origin of hepatic flow waves aids in understanding common pathologic alterations. For example, severe pulmonary hypertension can manifest as prominent A waves and/or decreased D wave amplitude because of an increase in RV end-diastolic pressure (45). Systolic dysfunction of the RV and tricuspid regurgitation (TR) both alter the RAP during ventricular systole, leading to progressive decrease in the peak velocity of the S wave (46). In addition, severe TR can cause S wave reversal (Figure 7B) (47). Thus, HV Doppler provides relevant information about the filling pattern of the RA.

Figure 7. Venous congestion assessment using pulsed wave Doppler. :
(A) Central venous pressure (CVP) waveform, hepatic vein (HV) and portal vein (PV) Doppler in a healthy person and (B) in a patient with severe biventricular failure, tricuspid regurgitation (TR), and venous congestion. HV flow mirrors changes in CVP waveform. Transmission of right atrial pressure to PV is only seen in the presence of severe venous congestion. Arrows in figure 7B are used to show the correlation of the phases of cardiac cycle between HV and PV. (C) HV and PV Doppler in a patient with pulmonary arterial hypertension and severe TR before and after diuretic therapy. Note the improvement in PV pulsatility fraction while HV alterations from severe TR remained unchanged. (D) Intrarenal venous (IRV) flow alterations in venous congestion. Waveform above the baseline corresponds to intrarenal arterial flow, whereas the waveform below the baseline depicts intrarenal venous flow. D, diastolic; S, syst olic; A, atrial contraction.

Portal Vein Doppler

As opposed to HV flow, the splanchnic circulation is an isolated vascular unit protected from the systemic circulation by the resistance of postsinusoidal sphincters (48). Thus, normal portal flow is continuous or only mildly pulsatile (Figure 7A) (49). However, pathologic increases in RAP can be transmitted through liver sinusoids into the portal vein (Figure 7B) (50). Portal vein pulsatility was originally described in patients with severe TR (51), but has now been described in multiple conditions associated with increased RAP (52,53). Increased pulsatility in portal venous flow has been associated with a higher N-terminal pro–brain natriuretic peptide (54), higher systolic pulmonary artery pressures (55), positive fluid balance (56), and RV dysfunction (56,57). Portal vein flow alterations can be quantified by the pulsatility fraction (100[(VmaxVmin)/Vmax]); a pulsatility fraction ≥30% is considered mild, whereas ≥50% is considered severely elevated (54).

There are a few studies evaluating the relationship between portal vein pulsatility and patient outcomes in the setting of HF. In a landmark study by Beaubien‐Souligny et al. (54), a portal vein pulsatility fraction of >50% and severe alterations in intrarenal venous flow (IRVF) were associated with an increased risk of AKI in patients who underwent cardiac surgery. The inclusion of portal vein Doppler significantly improved AKI risk prediction. Furthermore, alterations in portal vein flow have been associated with the development of congestive hepatopathy (58), encephalopathy (59), and major complications in patients undergoing cardiac surgery (56), and may be a useful prognostic marker in patients hospitalized for acute HF (60). Together, these data suggest that sonographic evaluation of portal vein pulsatility could become a useful tool for the diagnosis and management of venous congestion. In our experience, increased portal vein pulsatility fraction associated with volume overload often improves with diuretic treatment (61,62).

Although a plethoric, noncollapsible IVC indicates venous congestion, caution must be exercised when interpreting it in patients with cardiac conditions impeding venous return (chronic RV dysfunction/TR, RV myocardial infarction, cardiac tamponade); these patients may be fluid responsive despite IVC plethora (63). The evaluation of hemodynamic AKI in these conditions can be enhanced by assessing portal vein flow; increased portal pulsatility is suggestive of congestive AKI, which can potentially improve with decongestive therapy (62). A case of portal vein flow normalization with diuresis, even in the presence of persistent severe TR, is presented in Figure 7C.

Portal venous flow cannot be relied upon in patients with cirrhosis because both absent pulsatility in the presence of severe congestion and increased pulsatility unrelated to RAP can occur (646566–67). Occasionally, portal vein pulsatility can be seen in individuals who are thin and healthy (68). Given these limitations, portal vein pulsatility fraction should not be interpreted in isolation. A recent study evaluating IVC size and hepatic, portal, and intrarenal vein Doppler flow patterns found increased specificity using the combination of multiple POCUS markers to identify clinically significant venous congestion (69).

Intrarenal Venous Doppler

Similar to the portal vein, the flow pattern in intrarenal (arcuate and interlobar) veins depends on the surrounding renal parenchymal histology as much as right atrium function (70). Iida et al. (71) used Doppler imaging to evaluate IRVF patterns in patients with HF. IRVF waveforms were divided into three flow patterns: continuous, biphasic, and monophasic (Figure 7D). The IRVF profile was altered by increases in RAP, but was not associated with changes in cardiac index. The monophasic pattern was associated with significant TR. IRVF strongly correlated with clinical outcomes, including death from cardiovascular disease or unplanned hospitalization for HF. This correlation was independent of RAP. Similar results were obtained by Puzzovivo and colleagues (72).

Supporting the role of IRVF alterations as a marker of venous congestion, experimental fluid expansion worsened the IRVF pattern and correlated with less diuretic efficiency in patients with HF with preserved ejection fraction (73). A recent study in patients with pulmonary hypertension also showed adverse outcomes were associated with IRVF alterations (74). Three patients from this study who developed severe AKI with diuretic-resistant fluid overload and required RRT exhibited a monophasic IRVF pattern.

Whereas HV Doppler mainly reflects the right atrium filling pattern, portal and intrarenal venous Doppler provide additional information about right atrial filling pressure and its correlation with congestive organ injury (43). Whether interventions aimed at addressing abnormal organ flow patterns can improve relevant outcomes in patients with venous congestion remains unknown. Moreover, the cause-effect relationship between sonographic markers of venous congestion and AKI remains elusive at this time and must be evaluated by larger studies. POCUS alterations that occur in venous congestion are summarized in Figure 8.

Figure 8.:
Summary of POCUS alterations that occur in venous congestion. IVC size increases with an increase in RAP, and reaches its maximum compliance after a certain point. HV waveform initially shows both systolic and diastolic components and, as the congestion worsens, the systolic component reverses, leaving only the diastolic wave below the baseline. By convention, above the baseline represents flow toward the transducer, and below the baseline represents flow away from the transducer (toward the heart in this case). The normal portal vein waveform is continuous and above the baseline. As the severity of congestion increases, it becomes pulsatile and flow reversal (below the baseline) is seen in systole, with further elevations in RAP. Normal intrarenal vein Doppler is similar to that of the portal vein, except that it is below the baseline (flow away from the transducer). As the congestion worsens, it becomes increasingly pulsatile, leaving only the diastolic component below the baseline in severe cases. Above the baseline tracing represents intrarenal arterial flow, which is helpful to identify systolic and diastolic phases.

Going Back to the Case

FOCUS revealed severely decreased LV ejection fraction and dilated RV with significantly reduced function. Numerous bilateral B-lines were present on LUS. IVC was 2.4 cm in diameter with no respiratory variation and there were no significant ascites (Figure 9A). These findings were compatible with HF with reduced ejection fraction and severe RV failure, and moderate pulmonary congestion. To evaluate for the presence of systemic venous congestion, a bedside Doppler ultrasonography was performed. HV Doppler demonstrated decreased D wave amplitude (seen in severe pulmonary hypertension and abnormal RV relaxation), portal vein pulsatility fraction of 100%, and a monophasic IRVF (Figure 9B). Although a plethoric IVC was suggestive of venous congestion, the presence of severe RV dysfunction and significant pulmonary hypertension makes it less reliable (can be chronically dilated) and the patient might still be fluid responsive. However, both portal and IRVF patterns indicated that backward transmission of RAP was significant enough to lead to abdominal organ congestion, suggesting congestive kidney injury.

Figure 9.:
Case POCUS findings. (A) IVC, lung ultrasound (LUS), parasternal long axis (PLAx), and apical four-chamber (A4ch) views. (B) Venous Doppler obtained before restarting diuretics. (C) IVC and venous Doppler on follow-up after restarting diuretics. Ao, ascending aorta; B, B-line; IRV, intrarenal vein; PV, portal vein.

Treatment and Outcome

Given these findings, diuretic therapy was restarted with dose intensification. On follow-up, the patient showed a steady decrease in weight (approximately 10 kg) and noticeable improvement in symptoms. Although his serum creatinine worsened from 1.4 to 1.8 mg/dl initially, it improved and stabilized at 0.6 mg/dl with continued diuresis. Follow-up POCUS evaluation of venous congestion showed markedly improved flow patterns on both portal vein (pulsatility fraction=32% ) and IRVF (biphasic pattern) (Figure 9C).

POCUS Education and Program Development

Despite the stated advantages of POCUS and growing interest among nephrologists to acquire this skill, training opportunities remain sparse at this time. Workshops and short courses organized by professional societies, such as the National Kidney Foundation and the American Society of Nephrology, provide an introduction to the technique and interpretation, but continued practice, preferably under supervision, is vital to achieve mastery. Longitudinal curricula are shown to have a favorable effect on long-term skill retention (75,76); as such, integrating POCUS training into the 2-year nephrology fellowship offers a conceivable advantage. Nevertheless, only a few nephrology programs currently train their fellows beyond kidney ultrasound (77), the key problem being lack of trained faculty. We suggest that nephrology divisions identify faculty interested in learning/teaching POCUS and support them to pursue a structured, multicomponent certification program such as the one offered by the American College of Chest Physicians (78). Thereafter, multispecialty collaboration at the institutional level, with specialties such as emergency medicine and radiology, facilitates organizing the curriculum, training more faculty, and quality assurance. In addition, taking advantage of the online POCUS educational tools built for nephrologists, such as, minimizes the need to create new didactic material by individual fellowship programs. Furthermore, forming an expert panel and putting forward consensus guidelines by nephrology professional organizations would help standardize POCUS training.


Physical examination is limited in determination of fluid status. Augmented examination using POCUS is gaining popularity as a noninvasive bedside tool that provides a detailed insight into cardiovascular physiology and hemodynamic determinants of fluid status. Evaluation of cardiac function by FOCUS, pulmonary congestion by LUS, and systemic venous congestion by abdominal venous Doppler can guide management by providing information on fluid tolerance and responsiveness. Thorough multiorgan assessment should be undertaken to offset the limitations of individual POCUS applications. Integrating POCUS findings with clinical and laboratory data allows decisions regarding crystalloid administration or diuresis to be tailored according to the individual physiology with a risk-benefit analysis of the preferred therapeutic strategy. Further studies are needed to determine whether management guided by abnormalities detected on POCUS translates to improved clinical outcomes. On a note of caution, POCUS is not a replacement to clinical judgment and is susceptible to limitations like any other technology. Improper technique, wrong interpretation, and over-reliance on an isolated finding can potentially lead to mismanagement of the patient. Therefore, the nephrology community should focus on developing POCUS training standards and a robust certification process to ensure quality.


All autho rs have nothing to disclose.



Author Contributions

E. R. Argaiz, A. Koratala, and N. Reisinger conceptualized the study, wrote the original draft, and reviewed and edited the manuscript; and A. Koratala provided supervision.


1. Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Gueler F, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mussler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C: The agreement between auscultation and lung ultrasound in hemodialysis patients: The LUST study. Clin J Am Soc Nephrol 11: 2005–2011, 2016
2. Maw AM, Hassanin A, Ho PM, McInnes MDF, Moss A, Juarez-Colunga E, Soni NJ, Miglioranza MH, Platz E, DeSanto K, Sertich AP, Salame G, Daugherty SL: Diagnostic accuracy of point-of-care lung ultrasonography and chest radiography in adults with symptoms suggestive of acute decompensated heart failure: A systematic review and meta-analysis. JAMA Netw Open 2: e190703, 2019
3. Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ: Cardiac natriuretic peptides. Nat Rev Cardiol 17: 698–717, 2020
4. Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW; ESCAPE Investigators and ESCAPE Study Coordinators: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294: 1625–1633, 2005
5. Moore CL, Copel JA: Point-of-care ultrasonography. N Engl J Med 364: 749–757, 2011
6. Solomon SD, Saldana F: Point-of-care ultrasound in medical education--stop listening and look. N Engl J Med 370: 1083–1085, 2014
7. Vieillard-Baron A, Millington SJ, Sanfilippo F, Chew M, Diaz-Gomez J, McLean A, Pinsky MR, Pulido J, Mayo P, Fletcher N: A decade of progress in critical care echocardiography: A narrative review [published correction appears in Intensive Care Med 45: 911, 2019]. Intensive Care Med 45: 770–788, 2019
8. Marbach JA, Almufleh A, Di Santo P, Jung R, Simard T, McInnes M, Salameh JP, McGrath TA, Millington SJ, Diemer G, West FM, Domecq MC, Hibbert B: Comparative accuracy of focused cardiac ultrasonography and clinical examination for left ventricular dysfunction and valvular heart disease: A systematic review and meta-analysis. Ann Intern Med 171: 264–272, 2019
9. Lichtenstein D, Goldstein I, Mourgeon E, Cluzel P, Grenier P, Rouby JJ: Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology 100: 9–15, 2004
10. Cox EGM, Koster G, Baron A, Kaufmann T, Eck RJ, Veenstra TC, Hiemstra B, Wong A, Kwee TC, Tulleken JE, Keus F, Wiersema R, van der Horst ICC; SICS Study Group: Should the ultrasound probe replace your stethoscope? A SICS-I sub-study comparing lung ultrasound and pulmonary auscultation in the critically ill. Crit Care 24: 14, 2020
11. Panoulas VF, Daigeler AL, Malaweera AS, Lota AS, Baskaran D, Rahman S, Nihoyannopoulos P: Pocket-size hand-held cardiac ultrasound as an adjunct to clinical examination in the hands of medical students and junior doctors. Eur Heart J Cardiovasc Imaging 14: 323–330, 2013
12. Di Bello V, La Carrubba S, Conte L, Fabiani I, Posteraro A, Antonini-Canterin F, Barletta V, Nicastro I, Mariotti E, Severino S, Caso P, Benedetto F, Savino K, Carerj S; SIEC (Italian Society of Cardiovascular Echography): Incremental value of pocket-sized echocardiography in addition to physical examination during inpatient cardiology evaluation: A multicenter Italian study (SIEC). Echocardiography 32: 1463–1470, 2015
13. Koratala A, Kazory A: Point of care ultrasonography for objective assessment of heart failure: Integration of cardiac, vascular, and extravascular determinants of volume status. Cardiorenal Med 11: 5–17, 2021
14. Picano E, Scali MC, Ciampi Q, Lichtenstein D: Lung ultrasound for the cardiologist. JACC Cardiovasc Imaging 11: 1692–1705, 2018
15. Gargani L, Sicari R, Raciti M, Serasini L, Passera M, Torino C, Letachowicz K, Ekart R, Fliser D, Covic A, Balafa O, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Shavit L, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Kraemer TD, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Onofriescu M, Zarzoulas F, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C: Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: A LUST trial sub-project. Nephrol Dial Transplant 31: 1982–1988, 2016
16. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS): International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 38: 577–591, 2012
17. Gargani L, Volpicelli G: How I do it: Lung ultrasound. Cardiovasc Ultrasound 12: 25, 2014
18. Torino C, Tripepi R, Loutradis C, Sarafidis P, Tripepi G, Mallamaci F, Zoccali C: Can the assessment of ultrasound lung water in haemodialysis patients be simplified? [published online ahead of print December 29, 2020]. Nephrol Dial Transplant 2020 10.1093/ndt/gfaa285
19. Hubert A, Girerd N, Le Breton H, Galli E, Latar I, Fournet M, Mabo P, Schnell F, Leclercq C, Donal E: Diagnostic accuracy of lung ultrasound for identification of elevated left ventricular filling pressure. Int J Cardiol 281: 62–68, 2019
20. Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F; Lung US in CKD Working Group: Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol 24: 639–646, 2013
21. Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N: Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17: 1172–1181, 2015
22. Platz E, Campbell RT, Claggett B, Lewis EF, Groarke JD, Docherty KF, Lee MMY, Merz AA, Silverman M, Swamy V, Lindner M, Rivero J, Solomon SD, McMurray JJV: Lung ultrasound in acute heart failure: Prevalence of pulmonary congestion and short- and long-term outcomes. JACC Heart Fail 7: 849–858, 2019
23. Platz E, Lewis EF, Uno H, Peck J, Pivetta E, Merz AA, Hempel D, Wilson C, Frasure SE, Jhund PS, Cheng S, Solomon SD: Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J 37: 1244–1251, 2016
24. Koratala A, Chamarthi G, Kazory A: Point-of-care ultrasonography for objective volume management in end-stage renal disease. Blood Purif 49: 132–136, 2020
25. Jiang C, Patel S, Moses A, DeVita MV, Michelis MF: Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients. Int Urol Nephrol 49: 2223–2230, 2017
26. Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A: Ultrasound assessment for extravascular lung water in patients undergoing hemodialysis. Time course for resolution. Chest 135: 1433–1439, 2009
27. Arun Thomas ET, Mohandas MK, George J: Comparison between clinical judgment and integrated lung and inferior vena cava ultrasonography for dry weight estimation in hemodialysis patients. Hemodial Int 23: 494–503, 2019
28. Loutradis C, Sarafidis PA, Ekart R, Papadopoulos C, Sachpekidis V, Alexandrou ME, Papadopoulou D, Efstratiadis G, Papagianni A, London G, Zoccali C: The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: A randomized controlled trial. Kidney Int 95: 1505–1513, 2019
29. Cortellaro F, Ceriani E, Spinelli M, Campanella C, Bossi I, Coen D, Casazza G, Cogliati C: Lung ultrasound for monitoring cardiogenic pulmonary edema. Intern Emerg Med 12: 1011–1017, 2017
30. Rivas-Lasarte M, Álvarez-García J, Fernández-Martínez J, Maestro A, López-López L, Solé-González E, Pirla MJ, Mesado N, Mirabet S, Fluvià P, Brossa V, Sionis A, Roig E, Cinca J: Lung ultrasound-guided treatment in ambulatory patients with heart failure: A randomized controlled clinical trial (LUS-HF study). Eur J Heart Fail 21: 1605–1613, 2019
31. Lung Water by Ultrasound Guided Treatment in Hemodialysis Patients (The Lust Study), 2014. Available at: Https:// Accessed June 14, 2021
32. Cardenas-Garcia J, Mayo PH: Bedside ultrasonography for the intensivist. Crit Care Clin 31: 43–66, 2015
33. Labovitz AJ, Noble VE, Bierig M, Goldstein SA, Jones R, Kort S, Porter TR, Spencer KT, Tayal VS, Wei K: Focused cardiac ultrasound in the emergent setting: A consensus statement of the American Society of Echocardiography and American College of Emergency Physicians. J Am Soc Echocardiogr 23: 1225–1230, 2010
34. Pérez-Casares A, Cesar S, Brunet-Garcia L, Sanchez-de-Toledo J: Echocardiographic evaluation of pericardial effusion and cardiac tamponade. Front Pediatr 5: 79, 2017
35. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB: Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23: 685–713, quiz 786–788, 2010
36. Bowra J, Uwagboe V, Goudie A, Reid C, Gillett M: Interrater agreement between expert and novice in measuring inferior vena cava diameter and collapsibility index. Emerg Med Australas 27: 295–299, 2015
37. Akkaya A, Yesilaras M, Aksay E, Sever M, Atilla OD: The interrater reliability of ultrasound imaging of the inferior vena cava performed by emergency residents. Am J Emerg Med 31: 1509–1511, 2013
38. Kory P: COUNTERPOINT: Should acute fluid resuscitation be guided primarily by inferior vena cava ultrasound for patients in shock? No. Chest 151: 533–536, 2017
39. Koratala A: Utilizing point-of-care ultrasound in the cardiorenal clinic to enhance patient care. J Bras Nefrol 43: 135–136, 2021 10.1590/2175-8239-JBN-2020-0234
40. Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM: Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 141: 678–693, 2020
41. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WHW: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589–596, 2009
42. Smith HJ, Grøttum P, Simonsen S: Ultrasonic assessment of abdominal venous return. I. Effect of cardiac action and respiration on mean velocity pattern, cross-sectional area and flow in the inferior vena cava and portal vein. Acta Radiol Diagn (Stockh) 26: 581–588, 1985
43. Tang WHW, Kitai T: Intrarenal venous flow: A window into the congestive kidney failure phenotype of heart failure? JACC Heart Fail 4: 683–686, 2016
44. Reynolds T, Appleton CP: Doppler flow velocity patterns of the superior vena cava, inferior vena cava, hepatic vein, coronary sinus, and atrial septal defect: A guide for the echocardiographer. J Am Soc Echocardiogr 4: 503–512, 1991
45. Zhang A, Himura Y, Kumada T, Hayashida W, Ishikawa N, Noda M, Kohno F, Kambayashi M, Kawai C: The characteristics of hepatic venous flow velocity pattern in patients with pulmonary hypertension by pulsed Doppler echocardiography. Jpn Circ J 56: 317–324, 1992
46. Wranne B, Pinto FJ, Hammarström E, St Goar FG, Puryear J, Popp RL: Abnormal right heart filling after cardiac surgery: Time course and mechanisms. Br Heart J 66: 435–442, 1991
47. Shapira Y, Porter A, Wurzel M, Vaturi M, Sagie A: Evaluation of tricuspid regurgitation severity: Echocardiographic and clinical correlation. J Am Soc Echocardiogr 11: 652–659, 1998
48. Mitzner W: Hepatic outflow resistance, sinusoid pressure, and the vascular waterfall. Am J Physiol 227: 513–519, 1974
49. Taylor KJW, Burns PN: Duplex Doppler scanning in the pelvis and abdomen. Ultrasound Med Biol 11: 643–658, 1985
50. Greenway CV, Lautt WW: Distensibility of hepatic venous resistance sites and consequences on portal pressure. Am J Physiol 254: H452–H428, 1988
51. Abu-Yousef MM, Milam SG, Farner RM: Pulsatile portal vein flow: A sign of tricuspid regurgitation on duplex Doppler sonography. AJR Am J Roentgenol 155: 785–788, 1990
52. Catalano D, Caruso G, DiFazzio S, Carpinteri G, Scalisi N, Trovato GM: Portal vein pulsatility ratio and heart failure. J Clin Ultrasound 26: 27–31, 1998<27::AID-JCU6>3.0.CO;2-L
53. Shih CY, Yang SS, Hu JT, Lin CL, Lai YC, Chang CW: Portal vein pulsatility index is a more important indicator than congestion index in the clinical evaluation of right heart function. World J Gastroenterol 12: 768–771, 2006
54. Beaubien-Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chassé M, Desjardins G, Lamarche Y, White M, Bouchard J, Denault A: Alterations in portal vein flow and intrarenal venous flow are associated with acute kidney injury after cardiac surgery: A prospective observational cohort study. J Am Heart Assoc 7: e009961, 2018
55. Beaubien-Souligny W, Rhéaume M, Blondin MC, El-Barnachawy S, Fortier A, Éthier J, Legault L, Denault AY: A simplified approach to extravascular lung water assessment using point-of-care ultrasound in patients with end-stage chronic renal failure undergoing hemodialysis. Blood Purif 45: 79–87, 2018
56. Eljaiek R, Cavayas YA, Rodrigue E, Desjardins G, Lamarche Y, Toupin F, Denault AY, Beaubien-Souligny W: High postoperative portal venous flow pulsatility indicates right ventricular dysfunction and predicts complications in cardiac surgery patients. Br J Anaesth 122: 206–214, 2019
57. Singh NG, Kumar KN, Nagaraja PS, Manjunatha N: Portal venous pulsatility fraction, a novel transesophageal echocardiographic marker for right ventricular dysfunction in cardiac surgical patients. Ann Card Anaesth 23: 39–42, 2020
58. Styczynski G, Milewska A, Marczewska M, Sobieraj P, Sobczynska M, Dabrowski M, Kuch-Wocial A, Szmigielski C: Echocardiographic correlates of abnormal liver tests in patients with exacerbation of chronic heart failure. J Am Soc Echocardiogr 29: 132–139, 2016
59. Benkreira A, Beaubien-Souligny W, Mailhot T, Bouabdallaoui N, Robillard P, Desjardins G, Lamarche Y, Cossette S, Denault A: Portal hypertension is associated with congestive encephalopathy and delirium after cardiac surgery. Can J Cardiol 35: 1134–1141, 2019
60. Kuwahara N, Honjo T, Kaihotsu K, Kamemura K, Nakayama K, Imanishi J, Sone N, Iwahashi M: The clinical impact of portal vein pulsatility on the prognosis of hospitalized acute heart failure patients. J Am Coll Cardiol 75: 940, 2020
61. Singh S, Koratala A: Utility of Doppler ultrasound derived hepatic and portal venous waveforms in the management of heart failure exacerbation. Clin Case Rep 8: 1489–1493, 2020
62. Argaiz ER, Rola P, Gamba G: Dynamic changes in portal vein flow during decongestion in patients with heart failure and cardio-renal syndrome: A POCUS case series. Cardiorenal Med 11: 59–66, 2021
63. Via G, Tavazzi G, Price S: Ten situations where inferior vena cava ultrasound may fail to accurately predict fluid responsiveness: A physiologically based point of view. Intensive Care Med 42: 1164–1167, 2016
64. Loperfido F, Lombardo A, Amico CM, Vigna C, Testa M, Rossi E, Costalunga A, Pennestri F, Biasucci LM: Doppler analysis of portal vein flow in tricuspid regurgitation. J Heart Valve Dis 2: 174–182, 1993
65. Baikpour M, Ozturk A, Dhyani M, Mercaldo ND, Pierce TT, Grajo JR, Samir AE: Portal venous pulsatility index: A novel biomarker for diagnosis of high-risk nonalcoholic fatty liver disease. AJR Am J Roentgenol 214: 786–791, 2020
66. Gorka W, Gorka TS, Lewall DB: Doppler ultrasound evaluation of advanced portal vein pulsatility in patients with normal echocardiograms. Eur J Ultrasound 8: 119–123, 1998
67. Wachsberg RH, Needleman L, Wilson DJ: Portal vein pulsatility in normal and cirrhotic adults without cardiac disease. J Clin Ultrasound 23: 3–15, 1995
68. Gallix BP, Taourel P, Dauzat M, Bruel JM, Lafortune M: Flow pulsatility in the portal venous system: A study of Doppler sonography in healthy adults. AJR Am J Roentgenol 169: 141–144, 1997
69. Beaubien-Souligny W, Rola P, Haycock K, Bouchard J, Lamarche Y, Spiegel R, Denault AY: Quantifying systemic congestion with Point-Of-Care ultrasound: Development of the venous excess ultrasound grading system. Ultrasound J 12: 16, 2020
70. Jeong SH, Jung DC, Kim SH, Kim SH: Renal venous Doppler ultrasonography in normal subjects and patients with diabetic nephropathy: Value of venous impedance index measurements. J Clin Ultrasound 39: 512–518, 2011
71. Iida N, Seo Y, Sai S, Machino-Ohtsuka T, Yamamoto M, Ishizu T, Kawakami Y, Aonuma K: Clinical implications of intrarenal hemodynamic evaluation by doppler ultrasonography in heart failure. JACC Heart Fail 4: 674–682, 2016
72. Puzzovivo A, Monitillo F, Guida P, Leone M, Rizzo C, Grande D, Ciccone MM, Iacoviello M: Renal venous pattern: A new parameter for predicting prognosis in heart failure outpatients. J Cardiovasc Dev Dis 5: 52, 2018
73. Nijst P, Martens P, Dupont M, Tang WHW, Mullens W: Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients. JACC Heart Fail 5: 672–681, 2017
74. Husain-Syed F, Birk HW, Ronco C, Schörmann T, Tello K, Richter MJ, Wilhelm J, Sommer N, Steyerberg E, Bauer P, Walmrath HD, Seeger W, McCullough PA, Gall H, Ghofrani HA: Doppler-derived renal venous stasis index in the prognosis of right heart failure. J Am Heart Assoc 8: e013584, 2019
75. Kelm DJ, Ratelle JT, Azeem N, Bonnes SL, Halvorsen AJ, Oxentenko AS, Bhagra A: Longitudinal ultrasound curriculum improves long-term retention among internal medicine residents. J Grad Med Educ 7: 454–457, 2015
76. Hempel D, Stenger T, Campo Dell’ Orto M, Stenger D, Seibel A, Röhrig S, Heringer F, Walcher F, Breitkreutz R: Analysis of trainees’ memory after classroom presentations of didactical ultrasound courses. Crit Ultrasound J 6: 10, 2014
77. Koratala A, Segal MS, Kazory A: Integrating point-of-care ultrasonography into nephrology fellowship training: A model curriculum. Am J Kidney Dis 74: 1–5, 2019
78. American College of Chest Physicians: Point-of-care ultrasound certification program. Available at: Accessed March 29. 2021 Received October 30, 2020 Accepted May 26, 2021

hemodynamics and vascular regulation; congestion; doppler; fluid status; heart failure; hemodynamics; hypervolemia; POCUS; point of care ultrasound; VExUS; volume status

Copyright © 2021 by the American Society of Nephrology